United States Biotechnology & Medical Research

Veracyte Inc (VCYT)

Track

Track

Veracyte Inc. experienced significant insider trading activity recently, with twelve recorded transactions totaling over $2 million in sales. Executives, including the CEO and CFO, executed these planned divestments following a positive earnings report. Despite this selling pressure, the stock price declined 10% over the last quarter, currently trading near the middle of its annual range.
Ticker: VCYT Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Veracyte Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
McGuire Annie EVP, General Counsel Officer
Transaction date
Planned sale
Price
206.26
Quantity 84,640 +27.5%
Value US$3,903,498
McGuire Annie EVP, General Counsel Officer
Transaction date
Planned sale
Price
72.47
Quantity 15,322 -20.5%
Value US$1,427,186
Febbo Phillip G. Chief Scientific & Med Officer Officer
Transaction date
Planned sale
Price
379.43
Quantity 82,422 +29.3%
Value US$37,991
Febbo Phillip G. Chief Scientific & Med Officer Officer
Transaction date
Planned sale
Price
42.89
Quantity 1,000 -7.1%
Value US$100,000
0.7
Chambers Rebecca Chief Financial Officer Officer
Transaction date
Planned sale
Price
43.71
Quantity 1,000 -0.7%
Value US$100,000
0.7
Chambers Rebecca Chief Financial Officer Officer
Transaction date
Planned sale
Price
42.81
Quantity 1,000 -1.5%
Value US$100,000
0.7
REBECCA CHAMBERS Officer Officer
Transaction date
Proposed sale
Price
44.67
Quantity 1,000
Value US$100,000
PHILLIP FEBBO Officer Officer
Transaction date
Proposed sale
Price
44.67
Quantity 1,000
Value US$100,000
2.0
Bhanji Muna Non-Executive Director
Transaction date
Planned sale
Price
42.97
Quantity 1,000 -4.2%
Value US$100,000
EASTHAM KARIN Non-Executive Director
Transaction date
Planned sale
Price
53.55
Quantity 529 -3.4%
Value US$28,328
EASTHAM KARIN Non-Executive Director
Transaction date
Planned sale
Price
52.78
Quantity 3,200 -17.0%
Value US$168,906
KARIN EASTHAM Director Non-Executive Director
Transaction date
Proposed sale
Price
51.29
Quantity 3,729
Value US$191,260
2.6
Stapley Marc Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
50.12
Quantity 138,051 -23.9%
Value US$6,919,585
3.2
Leite John Global Chief Commercial Off Officer
Transaction date
Planned sale
Price
50.07
Quantity 13,975 -9.6%
Value US$699,732
McGuire Annie EVP, General Counsel Officer
Transaction date
Planned sale
Price
50.12
Quantity 1,776 -1.3%
Value US$89,007
McGuire Annie EVP, General Counsel Officer
Transaction date
Planned sale
Price
49.31
Quantity 1,400 -1.0%
Value US$69,029
0.7
Chambers Rebecca Chief Financial Officer Officer
Transaction date
Planned sale
Price
50.09
Quantity 1,961 -1.1%
Value US$98,229
0.7
Chambers Rebecca Chief Financial Officer Officer
Transaction date
Planned sale
Price
49.28
Quantity 1,600 -0.9%
Value US$78,854
ANN MCGUIRE Officer Officer
Transaction date
Proposed sale
Price
48.69
Quantity 3,176
Value US$154,639
3.2
John Leite Officer Officer
Transaction date
Proposed sale
Price
48.69
Quantity 13,975
Value US$680,443
2.6
MARC STAPLEY Director; Officer Executive Director
Transaction date
Proposed sale
Price
48.69
Quantity 138,051
Value US$6,721,703
0.7
REBECCA CHAMBERS Officer Officer
Transaction date
Proposed sale
Price
48.69
Quantity 3,561
Value US$173,385
3.1
Wygant Jonathan VP, Chief Accounting Officer Officer
Transaction date
Sale
Price
45.40
Quantity 24,000 -34.6%
Value US$1,089,624
EPSTEIN ROBERT S Non-Executive Director
Transaction date
Planned sale
Price
44.01
Quantity 10,000 -16.0%
Value US$440,129
ROBERT EPSTEIN Director Non-Executive Director
Transaction date
Proposed sale
Price
41.69
Quantity 10,000
Value US$416,900
McGuire Annie SVP, General Counsel Officer
Transaction date
Planned sale
Price
40.00
Quantity 5,102 -3.4%
Value US$204,080
McGuire Annie SVP, General Counsel Officer
Transaction date
Planned sale
Price
38.05
Quantity 5,102 -3.3%
Value US$194,131
ANN MCGUIRE Officer Officer
Transaction date
Proposed sale
Price
32.97
Quantity 10,204
Value US$336,426
McGuire Annie SVP, General Counsel Officer
Transaction date
Planned sale
Price
36.34
Quantity 1,664 -1.7%
Value US$60,469
McGuire Annie SVP, General Counsel Officer
Transaction date
Planned sale
Price
35.29
Quantity 4,994 -4.9%
Value US$176,256
2.6
Stapley Marc Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
36.28
Quantity 26,279 -6.8%
Value US$953,368
2.6
Stapley Marc Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
35.56
Quantity 19,244 -4.8%
Value US$684,226
0.7
Chambers Rebecca Chief Financial Officer Officer
Transaction date
Planned sale
Price
36.33
Quantity 13,941 -9.6%
Value US$506,460
0.7
Chambers Rebecca Chief Financial Officer Officer
Transaction date
Planned sale
Price
35.55
Quantity 4,400 -2.9%
Value US$156,409
3.2
Leite John Chief Commercial Officer-CLIA Officer
Transaction date
Planned sale
Price
35.19
Quantity 5,260 -4.7%
Value US$185,083
3.2
John Leite Officer Officer
Transaction date
Proposed sale
Price
35.08
Quantity 5,260
Value US$184,521
ANN MCGUIRE Officer Officer
Transaction date
Proposed sale
Price
35.08
Quantity 6,658
Value US$233,563
0.7
REBECCA CHAMBERS Officer Officer
Transaction date
Proposed sale
Price
35.08
Quantity 18,341
Value US$643,402
2.6
MARC STAPLEY Director; Officer Executive Director
Transaction date
Proposed sale
Price
35.08
Quantity 45,523
Value US$1,596,947
Febbo Phillip G. Chief Scientific & Med Officer Officer
Transaction date
Planned sale
Price
36.16
Quantity 13,425 -10.3%
Value US$485,429
PHILLIP FEBBO Officer Officer
Transaction date
Proposed sale
Price
36.59
Quantity 13,425
Value US$491,221
McGuire Annie SVP, General Counsel Officer
Transaction date
Planned sale
Price
43.68
Quantity 100 -0.1%
Value US$4,368
McGuire Annie SVP, General Counsel Officer
Transaction date
Planned sale
Price
43.13
Quantity 10,639 -13.6%
Value US$458,836
ANN MCGUIRE Officer Officer
Transaction date
Proposed sale
Price
43.53
Quantity 10,739
Value US$467,469
EASTHAM KARIN Non-Executive Director
Transaction date
Planned sale
Price
46.59
Quantity 800 -5.6%
Value US$37,272
EASTHAM KARIN Non-Executive Director
Transaction date
Planned sale
Price
45.84
Quantity 12,808 -47.2%
Value US$587,080
EASTHAM KARIN Non-Executive Director
Transaction date
Planned sale
Price
44.52
Quantity 6,392 -19.0%
Value US$284,571
KARIN EASTHAM Director Non-Executive Director
Transaction date
Proposed sale
Price
47.41
Quantity 20,000
Value US$948,200
ANN MCGUIRE Officer Officer
Transaction date
Proposed sale
Price
47.75
Quantity 1,422
Value US$67,900
0.7
REBECCA CHAMBERS Officer Officer
Transaction date
Proposed sale
Price
47.75
Quantity 13,278
Value US$634,024
2.6
MARC STAPLEY Director; Officer Executive Director
Transaction date
Proposed sale
Price
47.75
Quantity 7,668
Value US$366,147
McGuire Annie SVP, General Counsel Officer
Transaction date
Planned sale
Price
47.51
Quantity 702 -0.9%
Value US$33,352
McGuire Annie SVP, General Counsel Officer
Transaction date
Planned sale
Price
47.10
Quantity 720 -0.9%
Value US$33,909
3.2
Leite John Chief Commercial Officer-CLIA Officer
Transaction date
Planned sale
Price
47.51
Quantity 1,278 -1.5%
Value US$60,718
0.7
Chambers Rebecca Chief Financial Officer Officer
Transaction date
Planned sale
Price
47.25
Quantity 4,741 -4.2%
Value US$224,009
0.7
Chambers Rebecca Chief Financial Officer Officer
Transaction date
Planned sale
Price
46.61
Quantity 8,537 -7.0%
Value US$397,946
2.6
Stapley Marc Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
47.35
Quantity 3,220 -1.0%
Value US$152,462
2.6
Stapley Marc Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
46.90
Quantity 4,448 -1.4%
Value US$208,613
3.2
Leite John Chief Commercial Officer-CLIA Officer
Transaction date
Planned sale
Price
50.00
Quantity 2,808 -3.2%
Value US$140,400
1.6
JONES EVAN/ FA Non-Executive Director
Transaction date
Planned sale
Price
50.25
Quantity 1,106 -3.6%
Value US$55,576
1.6
Evan Jones Director Non-Executive Director
Transaction date
Proposed sale
Price
49.38
Quantity 5,000
Value US$246,900
3.2
John Leite Officer Officer
Transaction date
Proposed sale
Price
46.70
Quantity 4,086
Value US$190,816
1.5
Holstein Jens Non-Executive Director
Transaction date
Planned sale
Price
43.21
Quantity 1,460 -5.1%
Value US$63,086
1.5
Holstein Jens Non-Executive Director
Transaction date
Planned sale
Price
42.48
Quantity 7,049 -19.7%
Value US$299,417
1.5
Holstein Jens Non-Executive Director
Transaction date
Planned sale
Price
40.95
Quantity 1,491 -4.0%
Value US$61,060
1.5
JENS HOLSTEIN Director Non-Executive Director
Transaction date
Proposed sale
Price
42.36
Quantity 10,000
Value US$423,563
3.1
Wygant Jonathan VP, Chief Accounting Officer Officer
Transaction date
Sale
Price
42.33
Quantity 5,102 -11.6%
Value US$215,978
3.1
Wygant Jonathan VP, Chief Accounting Officer Officer
Transaction date
Sale
Price
40.21
Quantity 5,818 -11.7%
Value US$233,929
EASTHAM KARIN Non-Executive Director
Transaction date
Planned sale
Price
40.02
Quantity 9,674 -41.6%
Value US$387,191
1.6
JONES EVAN/ FA Non-Executive Director
Transaction date
Planned sale
Price
46.38
Quantity 657 -2.1%
Value US$30,469
1.6
JONES EVAN/ FA Non-Executive Director
Transaction date
Planned sale
Price
45.73
Quantity 24,296 -43.8%
Value US$1,110,990
1.6
JONES EVAN/ FA Non-Executive Director
Transaction date
Planned sale
Price
45.07
Quantity 5,872 -9.6%
Value US$264,640
1.6
JONES EVAN/ FA Non-Executive Director
Transaction date
Planned sale
Price
43.80
Quantity 10,837 -15.0%
Value US$474,702
1.6
JONES EVAN/ FA Non-Executive Director
Transaction date
Planned sale
Price
43.03
Quantity 1,126 -1.5%
Value US$48,455
1.6
JONES EVAN/ FA Non-Executive Director
Transaction date
Planned sale
Price
41.74
Quantity 408 -0.6%
Value US$17,031
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-04 2026-09-04 PlS Planned sale
McGuire Annie

EVP, General Counsel

Officer
84,640 +27.5%
206.26
US$3,903,498 		84,640 +27.5% 206.26 US$3,903,498
2026-09-04 2026-09-04 PlS Planned sale
McGuire Annie

EVP, General Counsel

Officer
15,322 -20.5%
72.47
US$1,427,186 		15,322 -20.5% 72.47 US$1,427,186
2026-09-04 2026-09-04 PlS Planned sale
Febbo Phillip G.

Chief Scientific & Med Officer

Officer
82,422 +29.3%
379.43
US$37,991 		82,422 +29.3% 379.43 US$37,991
2026-09-04 2026-09-04 PlS Planned sale
Febbo Phillip G.

Chief Scientific & Med Officer

Officer
1,000 -7.1%
42.89
US$100,000 		1,000 -7.1% 42.89 US$100,000
2026-09-04 2026-09-04 PlS Planned sale
0.7
Chambers Rebecca

Chief Financial Officer

Officer
1,000 -0.7%
43.71
US$100,000 		1,000 -0.7% 43.71 US$100,000
2026-09-04 2026-09-04 PlS Planned sale
0.7
Chambers Rebecca

Chief Financial Officer

Officer
1,000 -1.5%
42.81
US$100,000 		1,000 -1.5% 42.81 US$100,000
2026-09-04 2026-09-04 PrS Proposed sale
0.7
REBECCA CHAMBERS

Officer

Officer
1,000
44.67
US$100,000 		1,000 44.67 US$100,000
2026-09-04 2026-09-04 PrS Proposed sale
PHILLIP FEBBO

Officer

Officer
1,000
44.67
US$100,000 		1,000 44.67 US$100,000
2026-09-03 2026-09-01 PlS Planned sale
2.0
Bhanji Muna
Non-Executive Director
1,000 -4.2%
42.97
US$100,000 		1,000 -4.2% 42.97 US$100,000
2026-06-22 2026-06-18 PlS Planned sale
EASTHAM KARIN
Non-Executive Director
529 -3.4%
53.55
US$28,328 		529 -3.4% 53.55 US$28,328
2026-06-22 2026-06-18 PlS Planned sale
EASTHAM KARIN
Non-Executive Director
3,200 -17.0%
52.78
US$168,906 		3,200 -17.0% 52.78 US$168,906
2026-06-18 2026-06-18 PrS Proposed sale
KARIN EASTHAM

Director

Non-Executive Director
3,729
51.29
US$191,260 		3,729 51.29 US$191,260
2026-06-04 2026-06-04 PlS Planned sale
2.6
Stapley Marc

Chief Executive Officer

Executive Director
138,051 -23.9%
50.12
US$6,919,585 		138,051 -23.9% 50.12 US$6,919,585
2026-06-04 2026-06-04 PlS Planned sale
3.2
Leite John

Global Chief Commercial Off

Officer
13,975 -9.6%
50.07
US$699,732 		13,975 -9.6% 50.07 US$699,732
2026-06-04 2026-06-04 PlS Planned sale
McGuire Annie

EVP, General Counsel

Officer
1,776 -1.3%
50.12
US$89,007 		1,776 -1.3% 50.12 US$89,007
2026-06-04 2026-06-04 PlS Planned sale
McGuire Annie

EVP, General Counsel

Officer
1,400 -1.0%
49.31
US$69,029 		1,400 -1.0% 49.31 US$69,029
2026-06-04 2026-06-04 PlS Planned sale
0.7
Chambers Rebecca

Chief Financial Officer

Officer
1,961 -1.1%
50.09
US$98,229 		1,961 -1.1% 50.09 US$98,229
2026-06-04 2026-06-04 PlS Planned sale
0.7
Chambers Rebecca

Chief Financial Officer

Officer
1,600 -0.9%
49.28
US$78,854 		1,600 -0.9% 49.28 US$78,854
2026-06-04 2026-06-04 PrS Proposed sale
ANN MCGUIRE

Officer

Officer
3,176
48.69
US$154,639 		3,176 48.69 US$154,639
2026-06-04 2026-06-04 PrS Proposed sale
3.2
John Leite

Officer

Officer
13,975
48.69
US$680,443 		13,975 48.69 US$680,443
2026-06-04 2026-06-04 PrS Proposed sale
2.6
MARC STAPLEY

Director; Officer

Executive Director
138,051
48.69
US$6,721,703 		138,051 48.69 US$6,721,703
2026-06-04 2026-06-04 PrS Proposed sale
0.7
REBECCA CHAMBERS

Officer

Officer
3,561
48.69
US$173,385 		3,561 48.69 US$173,385
2026-05-27 2026-05-22 S Sale
3.1
Wygant Jonathan

VP, Chief Accounting Officer

Officer
24,000 -34.6%
45.40
US$1,089,624 		24,000 -34.6% 45.40 US$1,089,624
2026-05-22 2026-05-20 PlS Planned sale
EPSTEIN ROBERT S
Non-Executive Director
10,000 -16.0%
44.01
US$440,129 		10,000 -16.0% 44.01 US$440,129
2026-05-20 2026-05-20 PrS Proposed sale
ROBERT EPSTEIN

Director

Non-Executive Director
10,000
41.69
US$416,900 		10,000 41.69 US$416,900
2026-05-08 2026-05-06 PlS Planned sale
McGuire Annie

SVP, General Counsel

Officer
5,102 -3.4%
40.00
US$204,080 		5,102 -3.4% 40.00 US$204,080
2026-05-08 2026-05-06 PlS Planned sale
McGuire Annie

SVP, General Counsel

Officer
5,102 -3.3%
38.05
US$194,131 		5,102 -3.3% 38.05 US$194,131
2026-05-06 2026-05-06 PrS Proposed sale
ANN MCGUIRE

Officer

Officer
10,204
32.97
US$336,426 		10,204 32.97 US$336,426
2026-03-06 2026-03-04 PlS Planned sale
McGuire Annie

SVP, General Counsel

Officer
1,664 -1.7%
36.34
US$60,469 		1,664 -1.7% 36.34 US$60,469
2026-03-06 2026-03-04 PlS Planned sale
McGuire Annie

SVP, General Counsel

Officer
4,994 -4.9%
35.29
US$176,256 		4,994 -4.9% 35.29 US$176,256
2026-03-06 2026-03-04 PlS Planned sale
2.6
Stapley Marc

Chief Executive Officer

Executive Director
26,279 -6.8%
36.28
US$953,368 		26,279 -6.8% 36.28 US$953,368
2026-03-06 2026-03-04 PlS Planned sale
2.6
Stapley Marc

Chief Executive Officer

Executive Director
19,244 -4.8%
35.56
US$684,226 		19,244 -4.8% 35.56 US$684,226
2026-03-06 2026-03-04 PlS Planned sale
0.7
Chambers Rebecca

Chief Financial Officer

Officer
13,941 -9.6%
36.33
US$506,460 		13,941 -9.6% 36.33 US$506,460
2026-03-06 2026-03-04 PlS Planned sale
0.7
Chambers Rebecca

Chief Financial Officer

Officer
4,400 -2.9%
35.55
US$156,409 		4,400 -2.9% 35.55 US$156,409
2026-03-06 2026-03-04 PlS Planned sale
3.2
Leite John

Chief Commercial Officer-CLIA

Officer
5,260 -4.7%
35.19
US$185,083 		5,260 -4.7% 35.19 US$185,083
2026-03-04 2026-03-04 PrS Proposed sale
3.2
John Leite

Officer

Officer
5,260
35.08
US$184,521 		5,260 35.08 US$184,521
2026-03-04 2026-03-04 PrS Proposed sale
ANN MCGUIRE

Officer

Officer
6,658
35.08
US$233,563 		6,658 35.08 US$233,563
2026-03-04 2026-03-04 PrS Proposed sale
0.7
REBECCA CHAMBERS

Officer

Officer
18,341
35.08
US$643,402 		18,341 35.08 US$643,402
2026-03-04 2026-03-04 PrS Proposed sale
2.6
MARC STAPLEY

Director; Officer

Executive Director
45,523
35.08
US$1,596,947 		45,523 35.08 US$1,596,947
2026-03-04 2026-03-02 PlS Planned sale
Febbo Phillip G.

Chief Scientific & Med Officer

Officer
13,425 -10.3%
36.16
US$485,429 		13,425 -10.3% 36.16 US$485,429
2026-03-02 2026-03-02 PrS Proposed sale
PHILLIP FEBBO

Officer

Officer
13,425
36.59
US$491,221 		13,425 36.59 US$491,221
2025-12-17 2025-12-16 PlS Planned sale
McGuire Annie

SVP, General Counsel

Officer
100 -0.1%
43.68
US$4,368 		100 -0.1% 43.68 US$4,368
2025-12-17 2025-12-16 PlS Planned sale
McGuire Annie

SVP, General Counsel

Officer
10,639 -13.6%
43.13
US$458,836 		10,639 -13.6% 43.13 US$458,836
2025-12-16 2025-12-16 PrS Proposed sale
ANN MCGUIRE

Officer

Officer
10,739
43.53
US$467,469 		10,739 43.53 US$467,469
2025-12-08 2025-12-05 PlS Planned sale
EASTHAM KARIN
Non-Executive Director
800 -5.6%
46.59
US$37,272 		800 -5.6% 46.59 US$37,272
2025-12-08 2025-12-05 PlS Planned sale
EASTHAM KARIN
Non-Executive Director
12,808 -47.2%
45.84
US$587,080 		12,808 -47.2% 45.84 US$587,080
2025-12-08 2025-12-05 PlS Planned sale
EASTHAM KARIN
Non-Executive Director
6,392 -19.0%
44.52
US$284,571 		6,392 -19.0% 44.52 US$284,571
2025-12-05 2025-12-05 PrS Proposed sale
KARIN EASTHAM

Director

Non-Executive Director
20,000
47.41
US$948,200 		20,000 47.41 US$948,200
2025-12-04 2025-12-04 PrS Proposed sale
ANN MCGUIRE

Officer

Officer
1,422
47.75
US$67,900 		1,422 47.75 US$67,900
2025-12-04 2025-12-04 PrS Proposed sale
0.7
REBECCA CHAMBERS

Officer

Officer
13,278
47.75
US$634,024 		13,278 47.75 US$634,024
2025-12-04 2025-12-04 PrS Proposed sale
2.6
MARC STAPLEY

Director; Officer

Executive Director
7,668
47.75
US$366,147 		7,668 47.75 US$366,147
2025-12-04 2025-12-04 PlS Planned sale
McGuire Annie

SVP, General Counsel

Officer
702 -0.9%
47.51
US$33,352 		702 -0.9% 47.51 US$33,352
2025-12-04 2025-12-04 PlS Planned sale
McGuire Annie

SVP, General Counsel

Officer
720 -0.9%
47.10
US$33,909 		720 -0.9% 47.10 US$33,909
2025-12-04 2025-12-04 PlS Planned sale
3.2
Leite John

Chief Commercial Officer-CLIA

Officer
1,278 -1.5%
47.51
US$60,718 		1,278 -1.5% 47.51 US$60,718
2025-12-04 2025-12-04 PlS Planned sale
0.7
Chambers Rebecca

Chief Financial Officer

Officer
4,741 -4.2%
47.25
US$224,009 		4,741 -4.2% 47.25 US$224,009
2025-12-04 2025-12-04 PlS Planned sale
0.7
Chambers Rebecca

Chief Financial Officer

Officer
8,537 -7.0%
46.61
US$397,946 		8,537 -7.0% 46.61 US$397,946
2025-12-04 2025-12-04 PlS Planned sale
2.6
Stapley Marc

Chief Executive Officer

Executive Director
3,220 -1.0%
47.35
US$152,462 		3,220 -1.0% 47.35 US$152,462
2025-12-04 2025-12-04 PlS Planned sale
2.6
Stapley Marc

Chief Executive Officer

Executive Director
4,448 -1.4%
46.90
US$208,613 		4,448 -1.4% 46.90 US$208,613
2025-11-26 2025-11-25 PlS Planned sale
3.2
Leite John

Chief Commercial Officer-CLIA

Officer
2,808 -3.2%
50.00
US$140,400 		2,808 -3.2% 50.00 US$140,400
2025-11-26 2025-11-25 PlS Planned sale
1.6
JONES EVAN/ FA
Non-Executive Director
1,106 -3.6%
50.25
US$55,576 		1,106 -3.6% 50.25 US$55,576
2025-11-25 2025-11-25 PrS Proposed sale
1.6
Evan Jones

Director

Non-Executive Director
5,000
49.38
US$246,900 		5,000 49.38 US$246,900
2025-11-25 2025-11-25 PrS Proposed sale
3.2
John Leite

Officer

Officer
4,086
46.70
US$190,816 		4,086 46.70 US$190,816
2025-11-21 2025-11-20 PlS Planned sale
1.5
Holstein Jens
Non-Executive Director
1,460 -5.1%
43.21
US$63,086 		1,460 -5.1% 43.21 US$63,086
2025-11-21 2025-11-20 PlS Planned sale
1.5
Holstein Jens
Non-Executive Director
7,049 -19.7%
42.48
US$299,417 		7,049 -19.7% 42.48 US$299,417
2025-11-21 2025-11-20 PlS Planned sale
1.5
Holstein Jens
Non-Executive Director
1,491 -4.0%
40.95
US$61,060 		1,491 -4.0% 40.95 US$61,060
2025-11-20 2025-11-20 PrS Proposed sale
1.5
JENS HOLSTEIN

Director

Non-Executive Director
10,000
42.36
US$423,563 		10,000 42.36 US$423,563
2025-11-12 2025-11-10 S Sale
3.1
Wygant Jonathan

VP, Chief Accounting Officer

Officer
5,102 -11.6%
42.33
US$215,978 		5,102 -11.6% 42.33 US$215,978
2025-11-12 2025-11-07 S Sale
3.1
Wygant Jonathan

VP, Chief Accounting Officer

Officer
5,818 -11.7%
40.21
US$233,929 		5,818 -11.7% 40.21 US$233,929
2025-11-07 2025-11-05 PlS Planned sale
EASTHAM KARIN
Non-Executive Director
9,674 -41.6%
40.02
US$387,191 		9,674 -41.6% 40.02 US$387,191
2025-11-07 2025-11-05 PlS Planned sale
1.6
JONES EVAN/ FA
Non-Executive Director
657 -2.1%
46.38
US$30,469 		657 -2.1% 46.38 US$30,469
2025-11-07 2025-11-05 PlS Planned sale
1.6
JONES EVAN/ FA
Non-Executive Director
24,296 -43.8%
45.73
US$1,110,990 		24,296 -43.8% 45.73 US$1,110,990
2025-11-07 2025-11-05 PlS Planned sale
1.6
JONES EVAN/ FA
Non-Executive Director
5,872 -9.6%
45.07
US$264,640 		5,872 -9.6% 45.07 US$264,640
2025-11-07 2025-11-05 PlS Planned sale
1.6
JONES EVAN/ FA
Non-Executive Director
10,837 -15.0%
43.80
US$474,702 		10,837 -15.0% 43.80 US$474,702
2025-11-07 2025-11-05 PlS Planned sale
1.6
JONES EVAN/ FA
Non-Executive Director
1,126 -1.5%
43.03
US$48,455 		1,126 -1.5% 43.03 US$48,455
2025-11-07 2025-11-05 PlS Planned sale
1.6
JONES EVAN/ FA
Non-Executive Director
408 -0.6%
41.74
US$17,031 		408 -0.6% 41.74 US$17,031
Explore more

More insider trading research around Veracyte Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America